Cargando…

Risk of new primary cancer in patients with oropharyngeal cancer.

The relative risk of subsequent cancers was evaluated for a total of 9,092 patients with lip and oropharyngeal cancer recorded between 1953 and 1989 in the nationwide Finnish Cancer Registry. The observed numbers of patients were compared with those expected on the basis of the incidence rates in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Söderholm, A. L., Pukkala, E., Lindqvist, C., Teppo, L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968814/
https://www.ncbi.nlm.nih.gov/pubmed/8142267
_version_ 1782134822487982080
author Söderholm, A. L.
Pukkala, E.
Lindqvist, C.
Teppo, L.
author_facet Söderholm, A. L.
Pukkala, E.
Lindqvist, C.
Teppo, L.
author_sort Söderholm, A. L.
collection PubMed
description The relative risk of subsequent cancers was evaluated for a total of 9,092 patients with lip and oropharyngeal cancer recorded between 1953 and 1989 in the nationwide Finnish Cancer Registry. The observed numbers of patients were compared with those expected on the basis of the incidence rates in the Finnish population. There were 1,130 patients (12%) with a new cancer. The standardised incidence ratio (SIR) of contracting a new primary cancer was 1.2 for lip cancer patients (95% CI 1.1-1.3) and 1.4 for patients with oropharyngeal cancer (95% CI 1.2-1.4). Among lip cancer patients, a statistically significant excess risk was found for subsequent cancers in the oropharyngeal area (SIR 1.9, 95% CI 1.1-3.1), larynx (SIR 2.0, 95% CI 1.2-2.9) and lung (SIR 1.4, 95% CI 1.3-1.6), i.e. for cancers with tobacco aetiology. Among patients with oropharyngeal cancer there was an excess of lip cancer (SIR, 3.5, 95% CI 1.5-6.9), lung cancer (SIR 1.8, 95% CI 1.3-2.3) and leukaemia (SIR 2.3, 95% CI 1.0-4.3). Radiotherapy for the first primary did not increase the risk of new cancer.
format Text
id pubmed-1968814
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19688142009-09-10 Risk of new primary cancer in patients with oropharyngeal cancer. Söderholm, A. L. Pukkala, E. Lindqvist, C. Teppo, L. Br J Cancer Research Article The relative risk of subsequent cancers was evaluated for a total of 9,092 patients with lip and oropharyngeal cancer recorded between 1953 and 1989 in the nationwide Finnish Cancer Registry. The observed numbers of patients were compared with those expected on the basis of the incidence rates in the Finnish population. There were 1,130 patients (12%) with a new cancer. The standardised incidence ratio (SIR) of contracting a new primary cancer was 1.2 for lip cancer patients (95% CI 1.1-1.3) and 1.4 for patients with oropharyngeal cancer (95% CI 1.2-1.4). Among lip cancer patients, a statistically significant excess risk was found for subsequent cancers in the oropharyngeal area (SIR 1.9, 95% CI 1.1-3.1), larynx (SIR 2.0, 95% CI 1.2-2.9) and lung (SIR 1.4, 95% CI 1.3-1.6), i.e. for cancers with tobacco aetiology. Among patients with oropharyngeal cancer there was an excess of lip cancer (SIR, 3.5, 95% CI 1.5-6.9), lung cancer (SIR 1.8, 95% CI 1.3-2.3) and leukaemia (SIR 2.3, 95% CI 1.0-4.3). Radiotherapy for the first primary did not increase the risk of new cancer. Nature Publishing Group 1994-04 /pmc/articles/PMC1968814/ /pubmed/8142267 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Söderholm, A. L.
Pukkala, E.
Lindqvist, C.
Teppo, L.
Risk of new primary cancer in patients with oropharyngeal cancer.
title Risk of new primary cancer in patients with oropharyngeal cancer.
title_full Risk of new primary cancer in patients with oropharyngeal cancer.
title_fullStr Risk of new primary cancer in patients with oropharyngeal cancer.
title_full_unstemmed Risk of new primary cancer in patients with oropharyngeal cancer.
title_short Risk of new primary cancer in patients with oropharyngeal cancer.
title_sort risk of new primary cancer in patients with oropharyngeal cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968814/
https://www.ncbi.nlm.nih.gov/pubmed/8142267
work_keys_str_mv AT soderholmal riskofnewprimarycancerinpatientswithoropharyngealcancer
AT pukkalae riskofnewprimarycancerinpatientswithoropharyngealcancer
AT lindqvistc riskofnewprimarycancerinpatientswithoropharyngealcancer
AT teppol riskofnewprimarycancerinpatientswithoropharyngealcancer